Is HIMS or IMCC more undervalued in 2026?

CirclFi compares Hims & Hers Health, Inc. (HIMS) and IM Cannabis Corp. (IMCC) using 13 institutional-grade valuation models. HIMS has a Quality of Company score of 6.7/10 while IMCC scores 5.4/10.

Which is a better buy — HIMS or IMCC?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do HIMS and IMCC valuations compare?

HIMS at $25.38 and IMCC at $0.29 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

HIMS vs IMCC Valuation Comparison 2026 — Intrinsic Value Analysis

HIMS

Drug Manufacturers - Specialty & Generic

Hims & Hers Health, Inc.

Quality

6.7

out of 10

Value Trap

LOW

Price

$25.38

Last close

Models

12/13

Active

IMCC

Drug Manufacturers - Specialty & Generic

IM Cannabis Corp.

Quality

5.4

out of 10

Value Trap

SAFE

Price

$0.29

Last close

Models

4/13

Active

Model-by-Model Comparison

Model	Type	HIMS Fair Value	HIMS Upside	IMCC Fair Value	IMCC Upside
Bayesian DCF	Intrinsic	$14.62	-42.4%	—	—
Earnings Power Value	Intrinsic	$3.51	-87.6%	$1.11	+282.0%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$4.60	-81.9%	$0.29	-2.1%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for HIMS vs IMCC — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

HIMS vs IMCC — Which Stock Is More Undervalued?

HIMS scores higher with a 6.7/10 quality rating vs IMCC's 5.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Hims & Hers Health, Inc. (HIMS) and IM Cannabis Corp. (IMCC) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

HIMS currently trades at $25.38 with a QOC of 6.7/10, while IMCC trades at $0.29 with a QOC of 5.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).